News | SPECT-CT | June 13, 2022

Offers enhanced SPECT and CT imaging functionalities, including 64-slice CT and automated SPECT motion correction, as well as automated workflow

Offers enhanced SPECT and CT imaging functionalities, including 64-slice CT and automated SPECT motion correction, as well as automated workflow

June 13, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Symbia Pro.specta, a single-photon emission computed tomography/computed tomography (SPECT/CT) system with advanced CT and SPECT imaging technologies. Capabilities include a low-dose CT of up to 64 slices for impressive detail, automatic SPECT motion correction for additional image clarity, and an intuitive and automated workflow to guide the user through the entire decision-making process of the examination. Designed to replace the Symbia Intevo family of SPECT/CT scanners, the Symbia Pro.specta is an all-purpose system that can be customized to accommodate a wide range of clinical exams, patient types, and department settings.

Historically, SPECT/CT has not been accessible to all healthcare providers. Instead, many institutions continue to use SPECT-only gamma cameras, which cannot always accommodate the clinical needs of a modern molecular imaging or radiology department. With its optimized, low-dose imaging, intuitive workflow, and ability to fit into most existing SPECT rooms, the Symbia Pro.specta SPECT/CT system removes barriers to SPECT/CT adoption and helps providers transition from SPECT-only and early-generation SPECT/CT systems.

At the heart of the Symbia Pro.specta is myExam Companion, which includes an intuitive user interface that eliminates the traditional manual and user-dependent SPECT/CT imaging workflow. myExam Companion provides automated tools to guide the user through every step of the exam’s decision-making process—from system and patient preparation to image acquisition and reconstruction to evaluation and postprocessing—so departments can achieve consistent results quickly and more easily, regardless of the patient, procedure, or user experience level. Another major innovation that is standard is data-driven patient motion correction, which automatically corrects for patient movement in a SPECT exam with the click of a button, improving image quality without adding complexity. Additionally, data-driven respiratory motion correction for cardiac examinations is available as an option.

Designed for all SPECT/CT imaging applications, the Symbia Pro.specta can be tailored as needed with specialized clinical tools for optimized imaging in cardiology, neurology, oncology, orthopedics, and more. Flexible detectors along with an accessible design facilitate imaging for a wide range of patient types—including pediatric, obese, and physically challenged patients—without compromising exam quality, patient comfort, or staff efficiency. The scanner also can be used for either stand-alone diagnostic CT or SPECT imaging, providing the user with the same intuitive interface for simpler operation.

The Symbia Pro.specta features a minimum of 32 and a maximum of 64 CT slices, and it comes standard with a tin filter and CT iterative reconstruction for ultra-low patient and room dose. Its advanced quantification capabilities help the user determine the patient’s response to therapy. Capable of imaging at any energy level, the scanner is primed for imaging the high-energy isotopes increasingly used in theranostics, an approach that combines diagnostic and therapeutic agents to treat patients.

“Siemens Healthineers is proud to introduce the Symbia Pro.specta SPECT/CT scanner, which provides our customers with the ideal vehicle for transitioning from their SPECT-only and first-generation SPECT/CT cameras to a state-of-the-art SPECT/CT scanner that can perform a full spectrum of nuclear medicine examinations,” said Jim Williams, PhD, Head of Siemens Healthineers Molecular Imaging. “The Symbia Pro.specta will help healthcare institutions overcome barriers to care by ensuring accessibility through its ease of use and ability to fit into existing SPECT rooms.”

The products and features mentioned herein are not commercially available in all countries. Their future availability cannot be guaranteed.

For more information: www.siemens-healthineers.com


Related Content

News | Radiology Business

May 22, 2024 — Medtronic has announced new preliminary data from the VERITAS clinical study using its ILLUMISITE ...

Time May 22, 2024
arrow
News | Proton Therapy

May 21, 2024 — IBA, a world leader in particle accelerator technology, announced that it has signed a contract with the ...

Time May 21, 2024
arrow
News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Artificial Intelligence

May 15, 2024 — Heart disease is the leading cause of mortality in the U.S., accounting for one out of every five deaths ...

Time May 15, 2024
arrow
News | Pediatric Imaging

May 15, 2024 — Transfer learning (TL) models trained on heterogeneous public datasets and fine-tuned using institutional ...

Time May 15, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Radiopharmaceuticals and Tracers

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
News | Pediatric Imaging

May 2, 2024 — Head and abdominal trauma is a leading cause of death for children. About 1%–2% of children who come to ...

Time May 02, 2024
arrow
Feature | Radiology Business

Beginning this spring, ITN will begin sending out a bi-monthly survey to our readers on a variety of topics, which we ...

Time May 02, 2024
arrow
Subscribe Now